EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors

Fei Zhu, Zheng Lu, Wenjing Tang, Guangya Zhao, Yingxiang Shao, Bowen Lu, Jiage Ding, Yanyan Zheng, Lin Fang, Huizhong Li, Gang Wang iD, Renjin Chen und 2 weitere

Journal for ImmunoTherapy of Cancer · 2024-08 · 12 (8) · e009869

DOI: 10.1136/jitc-2024-009869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 28.08.2024. Verfasst von Fei Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Aurora Kinase A. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, China Postdoctoral Science Foundation, Qing Lan Project of Jiangsu Province, Research Foundation of Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Targeting kinases presents a potential strategy for treating solid tumors; however, the therapeutic potential of vaccines targeting kinases remains uncertain.

Methods

Adenovirus (Ad) vaccines encoding Aurora kinase A (AURKA) or cyclin-dependent kinase 7 (CDK7) were developed, and their therapeutic potentials were investigated by various methods including western blot, flow cytometry, cytotoxic T lymphocyte assay, and enzyme-linked immunospot (ELISpot), in mouse and humanized solid tumor models.

Results

Co-immunization with Ad-AURKA/CDK7 effectively prevented subcutaneous tumor growth in the Renca, RM-1, MC38, and Hepa1-6 tumor models. In therapeutic tumor models, Ad-AURKA/CDK7 treatment impeded tumor growth and increased immune cell infiltration. Administration of Ad-AURKA/CDK7 promoted the induction and maturation of dendritic cell subsets and augmented multifunctional CD8 + T-cell antitumor immunity. Furthermore, the vaccine induced a long-lasting antitumor effect by promoting the generation of memory CD8 + T cells. Tumor recovery on CD8 + T-cell depletion underscored the indispensable role of these cells in the observed therapeutic effects. The potent efficacy of the Ad-AURKA/CDK7 vaccine was consistently demonstrated in lung metastasis, orthotopic, and humanized tumor models by inducing multifunctional CD8 + T-cell antitumor immune responses.

Conclusions

Our findings illustrate that the Ad-AURKA/CDK7 vaccine targeting dual kinases AURKA and CDK7 emerges as a promising and effective therapeutic approach for the treatment of solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesAurora Kinase AAnimalsMiceHumansAdenoviridaeCell Line, TumorCyclin-Dependent Kinase-Activating KinaseFemaleNeoplasmsAdenovirus VaccinesCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

DendriticImmunotherapySolid tumorT cellVaccine

Substanzen

Cancer VaccinesAurora Kinase ACyclin-Dependent Kinase-Activating KinaseAdenovirus Vaccines

Autor:innen und Institutionen

  • Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Clinical Laboratory, The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second Hospital, Huai'an, Jiangsu, China.
  • Department of Oncology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China chaidafei@xzhmu.edu.cn jnzheng@xzhmu.edu.cn crj@xzhmu.edu.cn.

ORCID-Profile: Gang Wang, Junnian Zheng, Dafei Chai

Förderung

  • National Key R&D Program of China
  • China Postdoctoral Science Foundation
  • Qing Lan Project of Jiangsu Province, Research Foundation of Xuzhou Medical University
  • Xuzhou Municipal Science and Technology Project
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, F., Lu, Z., Tang, W., Zhao, G., Shao, Y., Lu, B., Ding, J., Zheng, Y., Fang, L., Li, H., Wang, G., Chen, R., Zheng, J., & Chai, D. (2024). Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors. Journal for ImmunoTherapy of Cancer, 12(8), e009869. https://doi.org/10.1136/jitc-2024-009869

Vancouver

Zhu F, Lu Z, Tang W, Zhao G, Shao Y, Lu B, et al. Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors. Journal for ImmunoTherapy of Cancer. 2024;12(8):e009869. doi:10.1136/jitc-2024-009869

BibTeX
@article{Zhu2024,
  author = {Zhu, Fei and Lu, Zheng and Tang, Wenjing and Zhao, Guangya and Shao, Yingxiang and Lu, Bowen and Ding, Jiage and Zheng, Yanyan and Fang, Lin and Li, Huizhong and Wang, Gang and Chen, Renjin and Zheng, Junnian and Chai, Dafei},
  title = {Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {e009869},
  doi = {10.1136/jitc-2024-009869}
}
Kostenlos starten →